[The Blood-Brain Barrier (BBB) and in vitro BBB Models]

The BBB is a specialized vascular interface that protects the brain from harmful substances. Unlike peripheral vasculature, it restricts the movement of immune cells and inflammatory molecules under normal and disease conditions. Despite its importance, the mechanisms governing BBB regulation remain unclear. This uncertainty limits the development of neuroprotective strategies for neuroinflammatory conditions. Prior research has shown that BBB dysfunction is a common feature in neurological disorders. However, the precise physiological and pathological roles of the BBB are not fully understood. A key challenge is the absence of reliable human BBB models. This gap motivated the need to evaluate current in vitro systems and their limitations.

This review aims to synthesize current knowledge on BBB cellular components and in vitro models. The specific problem is the lack of a universally reliable model system for human BBB studies. The motivation stems from the need to better understand BBB function and disruption in disease contexts. By summarizing recent findings, the study seeks to guide future model development. The focus is on identifying strengths and weaknesses of existing approaches. This work does not propose new models but evaluates current ones. The goal is to inform researchers about suitable systems for specific experimental needs. The review does not claim to resolve all uncertainties but highlights unresolved issues.

The authors conducted a literature review of BBB cellular components and in vitro models. They analyzed recent findings related to BBB structure and function. The review approach included comparing various in vitro systems such as cell cultures and organotypic models. No single experimental technique was used; instead, the focus was on synthesizing published data. The authors evaluated the advantages and limitations of each model type. They considered factors like cell source, barrier integrity, and reproducibility. The synthesis was based on peer-reviewed articles published in the last decade. The review approach did not introduce new data but compiled existing evidence.

The BBB is composed of endothelial cells, pericytes, astrocytes, and basement membrane components. In vitro models vary in their ability to replicate these interactions. Some models use primary human cells, while others rely on immortalized cell lines. The strongest finding is that no single model fully replicates human BBB physiology. Each model has distinct advantages depending on the research question. For example, co-culture systems better mimic cell-cell interactions. Organotypic brain slices preserve native tissue architecture. The most recent findings suggest that 3D bioprinting and microfluidic systems are promising but still limited in reproducibility.

The authors propose that current in vitro models are useful but incomplete representations of the human BBB. They suggest that model selection should be based on the specific research question. The synthesis indicates that no single model is universally suitable. The findings imply that combining multiple model systems may yield more comprehensive insights. The authors do not claim that any model is essential for all studies. They emphasize the need for continued refinement of existing models. The implications are that future studies should consider model limitations when interpreting results. The review does not assert that a single model will soon replace others.